Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9)

Hani M. Babiker; Mohammed Milhem; Joseph Aisner; William Edenfield; Dale Shepard; Michael Savona; Swaminathan Iyer; Maen Abdelrahim; C. L. Beach; Barry Skikne; Eric Laille; Kao Tai Tsai; Thai Ho

doi:10.1007/s00280-020-04056-6

Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9)

Hani M. Babiker, Mohammed Milhem, Joseph Aisner, William Edenfield, Dale Shepard, Michael Savona, Swaminathan Iyer, Maen Abdelrahim, C. L. Beach, Barry Skikne, Eric Laille, Kao Tai Tsai, Thai Ho

Hematology/Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original publication of the article the author has found few incorrect values in the Table 1.

Original language	English (US)
Pages (from-to)	1009-1010
Number of pages	2
Journal	Cancer chemotherapy and pharmacology
Volume	85
Issue number	5
DOIs	https://doi.org/10.1007/s00280-020-04056-6
State	Published - May 1 2020

ASJC Scopus subject areas

Oncology
Toxicology
Pharmacology
Cancer Research
Pharmacology (medical)

Access to Document

10.1007/s00280-020-04056-6

Fingerprint

Dive into the research topics of 'Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9)'. Together they form a unique fingerprint.

Cite this

Babiker, H. M., Milhem, M., Aisner, J., Edenfield, W., Shepard, D., Savona, M., Iyer, S., Abdelrahim, M., Beach, C. L., Skikne, B., Laille, E., Tsai, K. T., & Ho, T. (2020). Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9). Cancer chemotherapy and pharmacology, 85(5), 1009-1010. https://doi.org/10.1007/s00280-020-04056-6

Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9). / Babiker, Hani M.; Milhem, Mohammed; Aisner, Joseph et al.
In: Cancer chemotherapy and pharmacology, Vol. 85, No. 5, 01.05.2020, p. 1009-1010.

Research output: Contribution to journal › Comment/debate › peer-review

Babiker, HM, Milhem, M, Aisner, J, Edenfield, W, Shepard, D, Savona, M, Iyer, S, Abdelrahim, M, Beach, CL, Skikne, B, Laille, E, Tsai, KT & Ho, T 2020, 'Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9)', Cancer chemotherapy and pharmacology, vol. 85, no. 5, pp. 1009-1010. https://doi.org/10.1007/s00280-020-04056-6

Babiker HM, Milhem M, Aisner J, Edenfield W, Shepard D, Savona M et al. Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9). Cancer chemotherapy and pharmacology. 2020 May 1;85(5):1009-1010. doi: 10.1007/s00280-020-04056-6

Babiker, Hani M. ; Milhem, Mohammed ; Aisner, Joseph et al. / Correction to : Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9). In: Cancer chemotherapy and pharmacology. 2020 ; Vol. 85, No. 5. pp. 1009-1010.

@article{10aa029611a740fda8aa227a1c624703,

title = "Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9)",

abstract = "In the original publication of the article the author has found few incorrect values in the Table 1.",

author = "Babiker, {Hani M.} and Mohammed Milhem and Joseph Aisner and William Edenfield and Dale Shepard and Michael Savona and Swaminathan Iyer and Maen Abdelrahim and Beach, {C. L.} and Barry Skikne and Eric Laille and Tsai, {Kao Tai} and Thai Ho",

note = "Publisher Copyright: {\textcopyright} 2020, Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2020",

month = may,

day = "1",

doi = "10.1007/s00280-020-04056-6",

language = "English (US)",

volume = "85",

pages = "1009--1010",

journal = "Cancer chemotherapy and pharmacology",

issn = "0344-5704",

publisher = "Springer Verlag",

number = "5",

}

TY - JOUR

T1 - Correction to

T2 - Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9)

AU - Babiker, Hani M.

AU - Milhem, Mohammed

AU - Aisner, Joseph

AU - Edenfield, William

AU - Shepard, Dale

AU - Savona, Michael

AU - Iyer, Swaminathan

AU - Abdelrahim, Maen

AU - Beach, C. L.

AU - Skikne, Barry

AU - Laille, Eric

AU - Tsai, Kao Tai

AU - Ho, Thai

PY - 2020/5/1

Y1 - 2020/5/1

N2 - In the original publication of the article the author has found few incorrect values in the Table 1.

AB - In the original publication of the article the author has found few incorrect values in the Table 1.

UR - http://www.scopus.com/inward/record.url?scp=85082331758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082331758&partnerID=8YFLogxK

U2 - 10.1007/s00280-020-04056-6

DO - 10.1007/s00280-020-04056-6

M3 - Comment/debate

C2 - 32215699

AN - SCOPUS:85082331758

SN - 0344-5704

VL - 85

SP - 1009

EP - 1010

JO - Cancer chemotherapy and pharmacology

JF - Cancer chemotherapy and pharmacology

IS - 5

ER -

Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this